Harry Erba, MD [slides]- The Survival Impact of Quizartinib Acute Myelogenous Leukemia 2 Mins Read38 Harry Paul Erba, MD Professor of Medicine Member of the Duke Cancer Institute This content features Harry Paul Erba, MD, who…
Harry Paul Erba, MD- Midostaurin and Second-Gen Inhibitors Acute Lymphoblastic Leukemia 1 Min Read20 Harry Paul Erba, MD Professor of Medicine and Member of the Duke Cancer Institute Harry Erba, MD, a respected Duke…
